Arcam successfully completes private placement of approximately SEK 348 million

Regulatory News:

Arcam today announces that it has completed a private placement of 400,000 new shares, providing the company with approximately SEK 348 million before transaction costs.

This press release may not be announced, published or distributed, directly or indirectly in the United States, Canada, Japan, New Zealand, South Africa, Switzerland or Australia.

The private placement, which was announced on December 16, 2013, has allowed Arcam to place 400,000 new shares with international institutional investors and qualified investors in Sweden at a price of SEK 870 per share through an accelerated book building procedure.

The proceeds from the private placement are intended to be used to finance and facilitate accelerated expansion, nearby acquisition opportunities and a development of the company, its market and its products.

For the purpose of the private placement, the Board of Directors of Arcam has resolved, pursuant to the authorization given by the extraordinary general meeting held on December 6, 2013, on a directed issue of 400,000 new shares. The purposes of the resolution to issue new shares, deviating from the shareholders’ preferential rights, are primarily to broaden the long-term international institutional ownership in Arcam, and to take advantage of an opportunity to raise capital for the above-mentioned purposes on attractive terms, thereby promoting Arcam’s ability to create further value for all shareholders.

Through the issue, the number of shares in Arcam increases by 400,000 from 4,185,408 to 4,585,408 and the share capital increases by SEK 1,600,000 from SEK 16,741,633.5 to SEK 18,341,633.5. The new issue results in an equity dilution of approximately 8.7 percent after completed issue. A large existing shareholder has undertaken to temporarily lend the number of shares required to facilitate prompt delivery to the subscribers.

In addition to the directed share issue, the CEO of Arcam, Magnus René, has divested 30,000 shares in the company, accounting for less than half of his total holding. Magnus René has entered into a lock-up agreement with Carnegie Investment Bank not to sell any further shares in the company over the coming 12 months.

The newly issued shares will be admitted to trading on NASDAQ OMX Stockholm and the company expects to have a prospectus approved for this purpose on or around January 8, 2014. Trading in the new shares is expected to start in close connection thereto.

"We are delighted by the interest shown by institutional investors, both in Sweden and internationally, and we welcome them on board as shareholders. The transaction strengthens Arcam’s financial position and enables the company to capitalize on the exciting opportunities arising as the market for 3D printing grows. It also helps us to maintain the high tempo in our current expansion”, says Magnus René, CEO of Arcam.

Financial and legal advisors

Carnegie Investment Bank has acted as manager and bookrunner, ABG Sundal Collier acted as co-lead manager, and Baker & McKenzie acted as legal advisor in connection with the directed share issue.

The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:40 on December 17, 2013.

Important information

The publication or distribution of this press release may in certain jurisdictions be subject to restriction by law, and persons in the jurisdictions where this press release has been published or distributed should inform themselves of and follow such legal restrictions. This press release does not contain or constitute an invitation or offer to acquire, subscribe to or otherwise trade with shares or other securities in Arcam.

This press release may not be made public, published or distributed, either directly or indirectly in the United States, Canada, Japan, New Zealand, South Africa, Switzerland, Australia or any other country where such procedures are subject in full or in part to legal restrictions. Nor may the information in this press release may not be communicated, reproduced or presented in any way that is in conflict with such restrictions. Failure to follow this instruction may involve a breach of the United States Securities Act from 1933, as amended, or applicable laws in other jurisdictions.

Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam’s market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.

________________________________________________________________________________________

Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com

This information was brought to you by Cision http://news.cision.com